ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to use an approved drug(Visudyne) for neovascular age-related
macular degeneration, which is essentially choroidal neovascularization for permeability and
vascular proliferation for the retinal circulation, to treat another permeable abnormality -
retinal capillary abnormalities - located eccentric to the central portion of the macula or
in the foveal region.